India’s India-EU FTA opens access to a $572.3 billion pharma and MedTech market, cutting tariffs and boosting exports, jobs, and manufacturing across key Indian states.
Lupin Limited has earned the highest ‘A’ leadership rating from CDP for climate change and water security, reinforcing its position among global sustainability leaders in the pharmaceutical industry.
.jpeg "Health Ministry Mandates Blue Strip on All Antimicrobial Drugs")
Union Health Ministry drafts rules mandating blue strip on antimicrobial drugs to curb AMR. Public comments invited; aligns with PM Modi’s antibiotic safety emphasis.
Panchkula-based Venus Remedies has received its second PLI incentive payout for FY25, taking total disbursements to 75%. The release follows the company meeting investment, production, and sales targets under the scheme.
Zydus Lifesciences said its Ankleshwar manufacturing facility received three observations from the USFDA after a recent inspection, adding that none of the findings were linked to data integrity issues.
Naprod Life Sciences has secured an ANVISA GMP renewal for its Tarapur manufacturing facility, reinforcing its compliance with Brazil’s regulatory standards and supporting continued exports of oncology and specialty pharmaceutical products.
Akums Drugs secures EU GMP renewal for Plant 1 and first-time approval for Plant 2 in Haridwar, boosting its global CDMO presence in regulated pharma markets.
Sanofi’s amlitelimab, a promising treatment for moderate-to-severe atopic dermatitis (AD), has shown robust results in two global Phase 3 studies. The findings, along with a favorable safety profile, highlight its potential to improve patients’ quali
Bayer and Vanderbilt University Medical Center (VUMC) have entered a five-year collaboration to accelerate the development of new therapies for cardiovascular and kidney diseases, combining expertise in drug discovery and clinical research.
Corona Remedies Limited has secured the Eurasian Economic Union – Good Manufacturing Practices (EAEU–GMP) certification, marking a significant milestone in its global expansion. Announced on January 22, 2026, this certification allows the compa...
, CDSCO.jpg "Fostering a Quality Culture in the Pharmaceutical Industry")